 ZYMEWORKS INCZYME |
| 29.2% | 24.41% | $600.4M | 23.0M | $575.2M | 23.0M | 00.00% | Unchanged |
| AANAPTYSBIO INCANAB |
| 25.86% | 18.55% | $531.9M | 7.9M | $437.0M | 7.9M | 00.00% | Unchanged |
| AAKTIS ONCOLOGY INCAKTS |
| 7.56% | 3.66% | $155.5M | 4.8M | $86.3M | 4.8M | 00.00% | Unchanged |
 CG ONCOLOGY INCCGON |
| 7.1% | 3.17% | $146.1M | 2.1M | $74.6M | 1.1M | +953,800+86.55% | Add |
| EETON PHARMACEUTICALS INC COMETON |
| 3.82% | 2.27% | $78.6M | 2.2M | $53.6M | 2.2M | 00.00% | Unchanged |
 CRISPR THERAPEUTICSCRSP |
| 3.68% | 2.8% | $75.8M | 1.4M | $66.1M | 1.4M | 00.00% | Unchanged |
| OORIC PHARMACEUTICALS INCORIC |
| 3.54% | 3.62% | $72.9M | 6.7M | $85.2M | 6.7M | 00.00% | Unchanged |
| FFIRST TRACKS BIOTHERAPEUTICSTRAX |
| 3.11% | — | $63.9M | 3.2M | $0 | 0 | +3.2M | New Buy |
| LLAKEFRONT BIOTHERAPEUTICS NVLKFT |
| 2.43% | 2.12% | $50.0M | 1.7M | $50.0M | 1.7M | 00.00% | Unchanged |
| NNEUROGENE INC COMNGNE |
| 1.94% | 1.09% | $40.0M | 1.3M | $25.6M | 1.3M | 00.00% | Unchanged |
 STOKE THERAPEUTICS INCSTOK |
| 1.17% | 0.14% | $24.0M | 735,000 | $3.3M | 100,000 | +635,000+635.00% | Add |
 FULCRUM THERAPEUTICS INC COMFULC |
| 1.17% | — | $24.0M | 6.5M | $0 | 0 | +6.5M | New Buy |
| LLEGEND BIOTECH CORPLEGN |
| 1.12% | — | $23.1M | 800,000 | $0 | 0 | +800,000 | New Buy |
| BBRIDGEBIO ONCOLOGY THERAPEUTBBOT |
| 1.05% | 1.07% | $21.5M | 2.8M | $25.3M | 2.8M | 00.00% | Unchanged |
| MMBX BIOSCIENCES INCMBX |
| 1.04% | 0.98% | $21.4M | 388,500 | $23.2M | 777,000 | -388,500-50.00% | Reduce |
| ZZENAS BIOPHARMA INCZBIO |
| 0.97% | 0.66% | $20.0M | 789,500 | $15.4M | 789,500 | 00.00% | Unchanged |
| AATARA BIOTHERAPEUTICS INCATRA |
| 0.87% | 0.02% | $17.8M | 1.6M | $471,075 | 99,593 | +1.5M+1,458.34% | Add |
 RELAY THERAPEUTICS INCRLAY |
| 0.63% | 0.8% | $13.1M | 697,948 | $19.0M | 1.9M | -1.2M-63.36% | Reduce |
| AAURA BIOSCIENCES INCAURA |
| 0.58% | — | $11.8M | 1.7M | $0 | 0 | +1.7M | New Buy |
| OODYSSEY THERAPEUTICS INCODTX |
| 0.51% | — | $10.4M | 555,555 | $0 | 0 | +555,555 | New Buy |
| EEIKON THERAPEUTICS INCEIKN |
| 0.46% | 0.33% | $9.6M | 732,606 | $7.8M | 732,606 | 00.00% | Unchanged |
 PHARVARIS N VPHVS |
| 0.4% | — | $8.1M | 235,000 | $0 | 0 | +235,000 | New Buy |
 ZURA BIO LTD CLASS A ORD SHSZURA |
| 0.34% | 0.3% | $7.0M | 1.2M | $7.0M | 1.2M | 00.00% | Unchanged |
| PPHATHOM PHARMACEUTICALS INCPHAT |
| 0.33% | 0.29% | $6.8M | 625,000 | $6.9M | 625,000 | 00.00% | Unchanged |
 NURIX THERAPEUTICS INCNRIX |
| 0.32% | — | $6.6M | 270,000 | $0 | 0 | +270,000 | New Buy |
| EERASCA INCERAS |
| 0.29% | 0.62% | $6.0M | 330,000 | $14.6M | 900,000 | -570,000-63.33% | Reduce |
| EELOXX PHARMACEUTICALS INCELOX |
| 0.27% | — | $5.6M | 400,000 | $0 | 0 | +400,000 | New Buy |
| AAARDVARK THERAPEUTICS INC COMAARD |
| 0.12% | — | $2.4M | 410,894 | $0 | 0 | +410,894 | New Buy |
| HHELIX ACQUISITION CORP IIIHLXC |
| 0.1% | 0.09% | $2.1M | 200,000 | $2.0M | 200,000 | 00.00% | Unchanged |
| MMEREO BIOPHARMA GROUP FUNSPONSORED ADR 1 ADR REPS 5 ORD SHSMREO |
| 0.02% | 0.19% | $317,700 | 1.0M | $4.4M | 13.4M | -12.4M-92.52% | Reduce |
| SSURROZEN INCSRZN |
| <0.01% | 0.01% | $73 | 4,444 | $129,454 | 4,444 | 00.00% | Unchanged |
